Jiashuo Wu

According to our database, Jiashuo Wu authored at least 5 papers between 2021 and 2023.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of four.

2023

DTSEA: A network-based drug target set enrichment analysis method for drug repurposing against COVID-19.

Yinchun Su, Jiashuo Wu, Xiangmei Li, Ji Li, Xilong Zhao, Bingyue Pan, Junling Huang, Qingfei Kong, Junwei Han

Comput. Biol. Medicine, June, 2023

iATMEcell: identification of abnormal tumor microenvironment cells to predict the clinical outcomes in cancer based on cell-cell crosstalk network.

Yuqi Sheng, Jiashuo Wu, Xiangmei Li, Jiayue Qiu, Ji Li, Qinyu Ge, Liang Cheng, Junwei Han

Briefings Bioinform., March, 2023

2022

DRviaSPCN: a software package for drug repurposing in cancer via a subpathway crosstalk network.

Jiashuo Wu, Xiangmei Li, Qian Wang, Junwei Han

Bioinform., October, 2022

A novel pathway mutation perturbation score predicts the clinical outcomes of immunotherapy.

Xiangmei Li, Yalan He, Jiashuo Wu, Jiayue Qiu, Ji Li, Qian Wang, Ying Jiang, Junwei Han

Briefings Bioinform., 2022

2021

CNA2Subpathway: identification of dysregulated subpathway driven by copy number alterations in cancer.

Yuqi Sheng, Ying Jiang, Yang Yang, Xiangmei Li, Jiayue Qiu, Jiashuo Wu, Liang Cheng, Junwei Han

Briefings Bioinform., 2021